Q4 2019 Sangamo Therapeutics Inc Earnings and Collaboration Agreement with Biogen Inc Call Transcript
Good morning, and welcome to the Sangamo Therapeutics Teleconference to discuss Fourth Quarter 2019 Financial Results. This call is being recorded. I will now pass you over to the coordinator of this event, McDavid Stilwell, Senior Vice President of Corporate Communication and Investor Relations.
Thank you for joining us today. Yesterday afternoon, we issued a press release announcing a global collaboration, and earlier this morning, we issued fourth quarter and full year 2019 results. During our call today, we'll be referencing slides from our corporate presentation, which can be found at our website, sangamo.com, under the Investors + Media section in the Events + Presentations page.
This call includes forward-looking statements. These statements include, but are not limited to, the timing and scope of Sangamo's genomic medicine platform and products, the potential for Sangamo's product candidates to provide clinical benefit to patients, Sangamo's collaborations
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
